More than 250,000 people worldwide, including 36,000 people in the United States, die from influenza (flu) or complications of the flu each year. Although flu medications are available, there is a need for additional, more-targeted treatments. Finding new treatments is the focus of this research study. We are seeking healthy volunteers for a new research study at the National Institutes of Health (NIH) that will evaluate the safety of an investigational medication called AVI-7100. This medication is thought to stop the flu virus from making copies of itself in the body.
You may be eligible if you are
To determine if you are eligible to participate in the study, you will visit the NIH Clinical Center in Bethesda, Maryland, for a screening visit. Participants will have 5 to 10 visits over one month and will receive the study medication into a vein in your arm.
The study is being conducted at the Warren Grant Magnuson Clinical Center (Building 10) at NIH. The NIH campus is accessible by car and public transportation.
There is no charge to participate in this research study. All study-related medical care and procedures are provided free of charge.
Yes, you will be compensated for your participation in the study. Transportation and other expenses may also be covered.
If you have questions or would like more information, please contact
Patient Recruitment, NIH Clinical CenterToll free: 1-800-411-1222 (reference 13-I-0029)TTY: 1-866-411-1010 Se habla español.Email: email@example.comOffice hours: 8:00 a.m.-3:30 p.m. Eastern Time
To learn more about this study (trial ID NCT01747148), visit ClinicalTrials.gov.
Last Updated July 11, 2013
Last Reviewed February 13, 2015